Zhili Song Selected Research

Monoclonal Antibodies

11/2022	Anti-CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping.
1/2020	Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhili Song Research Topics

Disease

4	Neoplasms (Cancer) 03/2022 - 01/2020
2	Multiple Myeloma 11/2022 - 01/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011
1	Hypertriglyceridemia 06/2011

Drug/Important Bio-Agent (IBA)

3	isatuximabIBA 11/2022 - 01/2020
2	Monoclonal AntibodiesIBA 11/2022 - 01/2020
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
2	Chimeric Antigen ReceptorsIBA 03/2022 - 01/2020
1	daratumumabIBA 11/2022
1	LigandsIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Bispecific AntibodiesIBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2011
1	Lipoproteins (Lipoprotein)IBA 06/2011
1	Triglycerides (Triacylglycerol)IBA 06/2011
1	Apolipoprotein C-IIIIBA 06/2011

Therapy/Procedure

1	Immunotherapy 01/2020